SRA-333
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SRA-333, covering 2009-09-04 to 2009-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD) [Phase 2]